Normalizing opioid use disorder treatments to improve care Today Comprehensive Center for Pain & Addiction leaders are increasing access to care and treatment for people with opioid use disorder through education, research and policy. Read more Image
De La Rosa accepted into pain group’s leadership academy Thursday The yearlong program includes mentorship, peer-group meetings and a capstone project. Read more Image
Should I talk to my doctor about cannabis? April 19, 2024 Pain management physician Mohab Ibrahim, MD, PhD, answers some important questions about the doctor-patient relationship when it comes to talking about cannabis. Read more Image
Cannabis education program seeks to inform and empower March 28, 2024 The University of Arizona Health Sciences’ Comprehensive Center for Pain & Addiction is distributing science-based cannabis information through AzCANN program. Read more Image
Managing substance use disorders with ‘empathy and love’ March 14, 2024 History, politics and morals converge in the field of harm reduction, which researchers say is about much more than telling people how to safely use drugs. Read more Image
Poor sleep linked to migraine attacks in new UArizona Health Sciences study March 13, 2024 Researchers at the Comprehensive Center for Pain & Addiction found that sleep disturbances increased vulnerability to migraine attacks, but the opposite isn’t true. Read more Image
Opioids focus of reimagine Health Research Symposium Feb. 9, 2024 Comprehensive Center for Pain & Addiction researchers presented at the 6th annual symposium. Read more Image
Lived experience leads to unique educational approach Dec. 8, 2023 Bridget Murphy's struggles as a teen fuel her work to educate the next generation of health professionals on how to address substance use disorders. Read more Image
Study seeks to transform methadone treatment for opioid use disorder Nov. 2, 2023 The MPACT study will develop and test a medical intervention to address critical gaps in current methadone maintenance treatment for opioid use disorder. Read more Image
Should cannabis still be a Schedule 1 drug? Oct. 9, 2023 The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule 3 drug, a move that would be a boon to research and patient care. Read more Image